These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35092226)

  • 1. Periprocedural outcomes of protamine administration after catheter ablation of atrial fibrillation.
    Kewcharoen J; Shah K; Bhardwaj R; Contractor T; Turagam MK; Mandapati R; Lakkireddy D; Garg J
    Rev Cardiovasc Med; 2022 Jan; 23(1):34. PubMed ID: 35092226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: A randomized controlled trial.
    Ghannam M; Chugh A; Dillon P; Alyesh D; Kossidas K; Sharma S; Coatney J; Atreya A; Yokokawa M; Saeed M; Cunnane R; Ghanbari H; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2018 Nov; 15(11):1642-1647. PubMed ID: 30661768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin reversal with protamine sulfate is not required in atrial fibrillation ablation with suture hemostasis.
    Yasar SJ; Bickel T; Zhang S; Akkaya M; Aznaurov SG; Krishnan K; Cuculich PS; Gautam S
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2811-2817. PubMed ID: 31661173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation.
    Conte G; de Asmundis C; Baltogiannis G; Di Giovanni G; Ciconte G; Sieira J; Saitoh Y; Wauters K; Mugnai G; Julià J; Irfan G; Levinstein M; Cotino-Moreno HE; Chierchia GB; Brugada P
    J Interv Card Electrophysiol; 2014 Nov; 41(2):129-34. PubMed ID: 24938637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation.
    Mao YJ; Wang H; Huang PF
    J Interv Card Electrophysiol; 2021 Apr; 60(3):407-417. PubMed ID: 32361948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
    Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
    Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
    Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
    Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study.
    Huang L; Yu Z; Liu M; Shang X
    Am J Cardiovasc Drugs; 2022 Sep; 22(5):557-565. PubMed ID: 35717554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin.
    Zhao Y; Yang Y; Tang X; Yu X; Zhang L; Xiao H
    J Interv Card Electrophysiol; 2017 Apr; 48(3):267-282. PubMed ID: 28078536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uninterrupted versus interrupted direct oral anticoagulation for catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
    Asad ZUA; Akhtar KH; Jafry AH; Khan MH; Khan MS; Munir MB; Lakkireddy DR; Gopinathannair R
    J Cardiovasc Electrophysiol; 2021 Jul; 32(7):1995-2004. PubMed ID: 33861494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation.
    Zhao Y; Lu Y; Qin Y
    Int J Cardiol; 2018 Nov; 270():167-171. PubMed ID: 29903520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation.
    Rahman H; Khan SU; DePersis M; Hammad T; Nasir F; Kaluski E
    Cardiovasc Revasc Med; 2019 Feb; 20(2):147-152. PubMed ID: 29786530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous hemostasis postcatheter ablation of atrial fibrillation while under therapeutic levels of oral and intravenous anticoagulation.
    Issa ZF; Amr BS
    J Interv Card Electrophysiol; 2015 Nov; 44(2):97-104. PubMed ID: 26223659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.